Synonyms Refractory Mature B-Cell Lymphoma, Refractory Mature B-Cell Neoplasm, Refractory Mature B-Cell Non-Hodgkin Lymphoma + [1] |
Introduction Mature B-cell non-Hodgkin lymphoma that does not respond to treatment. |
Target |
Mechanism BTK inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date13 Nov 2013 |
Target |
Mechanism BTK C481S inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism CD19 inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date16 Nov 2022 |
Sponsor / Collaborator |
Start Date28 Sep 2022 |
Sponsor / Collaborator |
Start Date27 Dec 2021 |
Sponsor / Collaborator- |